For references to recent and historical guidelines and updates relevant to Vitalant services and laboratory processes, including Coagulation and related Transfusion Medicine, please view the links below.
Summary Statement Vitalant Disaster Preparedness Plan 1.25.2021
Summary Statement Vitalant Quality Plan 1.25.2021
TRALI Mitigation Policy
Red Cell Contamination in Platelets and Apheresis Granulocytes
Blood Use Optimization
- Choosing Wisely Campaign: AABB List of Recommendations to Optimize Blood Use (Posted with permission from AABB.)
Bacterial Detection QC for Platelets
Babesia Microti Testing for Blood Collected in High-Risk Endemic States
Suspected Platelet Refractory State
- Evaluation of the Patient with Suspected Platelet Refractory State (PDF) (Physician's Guide)
Compliance Alert, January 2013: Important Information for All Laboratories
Rationale for Universal Leukoreduction (ULR)
Reintroduction of Nonleukoreduced Blood Components
- Commentary on the safety of the reintroduction of nonleukoreduced blood components in hospitals that previously implemented universal leukoreduction (Transfusion, 2011)
NAT in Blood Screening Around the World
- NAT in Blood Screening Around the World by Frank Strobl, MD, PhD
Compliance Alert, March 2011: Important Information for All Transfusion Services
Small Volume Transfusions in Neonates
- Small Volume Transfusions in Neonates: Red Cells in Additive Solution are an Acceptable Choice (PDF) by Leon Su, MD
Transfusion Medicine Updates
Transfusion Medicine Updates published from February 1992 to the present that are relevant to the Coagulation Laboratory.
2011 Issue #1, Dabigatran, a New Oral Anticoagulant & Its Role in Clinical Practice (PDF), Irina Chibisov, M.D., Andrea Cortese Hassett, Ph.D.
2005 Issue #4, Aspirin Resistance (PDF), Zella Zeigler, M.D.
2004 Issue #3, Quantitative D-dimer: Ruling out Venous Thrombosis (PDF), Andrea Cortese Hassett, Ph.D.
2002 Issue #5, Platelet Function Testing (PDF), Andrea Cortese Hassett, Ph.D.
2001 January, Activated Protein C Resistance (PDF), Andrea Cortese-Hassett, Ph.D., Franklin A. Bontempo, M.D.
2000 February, D-dimer Testing and Acute Venous Thromboembolism, (PDF) Andrea Cortese-Hassett, Ph.D.
2000 July, Closure Time Platelet Function Screening (PDF), Andrea Cortese-Hassett, Ph.D.
1996 February, Heparin Monitoring (PDF), Andrea Cortese-Hassett, Ph.D.
1996 June, Low Molecular Weight Heparin (PDF), Franklin A. Bontempo, M.D., Andrea Cortese-Hassett, Ph.D.
1995 June, The INR (International Normalized Ratio) FOR Monitoring Oral Anticoagulant Therapy (PDF), Andrea Cortese-Hassett, Ph.D., Frank A. Bontempo, M.D.
1995 August, The Factor V Leiden Mutation (PDF), Franklin A. Bontempo, M.D., Andrea Cortese-Hassett, Ph.D.
1994 April, Use and Misuse of the Bleeding Time (PDF), Franklin A. Bontempo, M.D.
1994 October, von Willebrand Disease (PDF), Margaret V. Ragni, M.D., M.P.H.